IGF1 and lung cancer: To evaluate time‐related variations of neuroendocrine and immune system components (GH‐IGF1 axis, hypothalamus–pituitary–thyroid axis, melatonin, cortisol, lymphocyte subsets and IL2) in lung cancer patients compared to healthy controls